Updated July 2026 · 7 min read

Neuroleptic Malignant Syndrome for ICU Nurses 2026 — Rigidity, Fever, and the Antipsychotic Trap

Part of the ICU Emergencies Hub — browse every related guide in one place.

Neuroleptic malignant syndrome is rare, but when it lands in the ICU it is a true emergency with a meaningful mortality if it is missed or treated as simple sepsis. It is the shadow side of an ordinary intervention — giving an antipsychotic to a patient who is agitated or delirious — and it evolves slowly enough that the connection to the drug is easy to lose. The nurse who notices rising rigidity and temperature over a day or two, and links it to a dopamine-blocking medication, is often the one who makes the diagnosis.

The mechanism, and why it matters at the bedside

NMS is driven by a sudden drop in dopamine activity in the brain and, importantly, in the pathways that regulate temperature and muscle tone. Blocking dopamine receptors — or removing the dopamine agonist a Parkinson's patient depends on — unleashes rigidity and impairs the body's ability to shed heat. The intense, continuous muscle contraction both generates heat and destroys muscle, which is why the creatine kinase (CK) climbs, sometimes into the tens of thousands, and why rhabdomyolysis and acute kidney injury are the feared complications. Understanding that the problem is too little dopamine explains the treatment logic: replace dopamine tone (bromocriptine) and break the muscle-driven heat production (dantrolene).

The tetrad and the tempo

Unlike serotonin syndrome, NMS builds over one to three days. That slow tempo is a diagnostic clue and a trap — it is slow enough to be blamed on infection.

The combination of a recently started or dose-changed antipsychotic (or a withheld Parkinson's medication), rigidity, fever, and a high CK is NMS until proven otherwise. It is a diagnosis of exclusion, so sepsis, meningitis/encephalitis, and other hyperthermic syndromes must be considered and worked up in parallel — but the medication history is what points the way.

NMS versus serotonin syndrome versus malignant hyperthermia

The fastest bedside discriminator is the reflex exam: NMS is rigidity with quiet reflexes; serotonin syndrome is clonus with brisk reflexes. The trigger and tempo close the case. See the malignant hyperthermia guide for the anesthetic-linked variant that shares the dantrolene treatment.

What kills these patients

Treatment

The first and most important step is to stop every dopamine-blocking agent — and, if the trigger was withdrawal of a Parkinson's medication, restart it. Everything else is aggressive supportive care: IV fluids to prevent renal injury from myoglobin, active cooling, correction of electrolytes, and continuous cardiac and temperature monitoring. Benzodiazepines help with agitation and mild cases. For moderate-to-severe NMS, the specific agents are dantrolene, which reduces muscle-driven heat production, and bromocriptine (a dopamine agonist) to restore dopamine tone; amantadine is an alternative. Severe cases need intubation and ICU-level support, and electroconvulsive therapy is a rescue option in refractory disease. Recovery typically takes days to weeks, and reintroducing any antipsychotic afterward is done cautiously and only when necessary.

The nursing bottom line

Neuroleptic malignant syndrome is the slow-burning hyperthermic emergency of dopamine blockade. It builds over days as rigidity, fever, autonomic instability, and clouded consciousness, with a high CK exposing the muscle breakdown underneath. The bedside key is rigidity with reduced reflexes, tied to a recently started antipsychotic or a withheld Parkinson's drug — the opposite reflex picture from serotonin syndrome. Management is stopping the trigger, restoring dopamine tone if withdrawal caused it, and delivering relentless supportive care with dantrolene and bromocriptine for severe disease, all while protecting the kidneys and the airway. The nurse who connects a rising temperature and stiffening muscles to a dopamine-blocking medication is the one who catches NMS in time to matter.

Related: Serotonin syndrome · Malignant hyperthermia · Rhabdomyolysis · CAM-ICU delirium assessment

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.